Cubist Systematic Strategies, LLC Magenta Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.97 - $3.08 $10,346 - $32,854	10,667 New	10,667 $13,000
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $109,645 - $191,521	-14,314 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $2,934 - $3,819	481 Added 3.48%	14,314 $112,000
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $90,191 - $123,667	13,833 New	13,833 $94,000
Q3 2018 Nov 14, 2018	SELL	$11.32 - $15.7 $8,490 - $11,775	-750 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $10,125 - $10,890	750 New	750 $10,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.